Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, ciprofloxacin/dexamethasone (Cilodex®) cannot be endorsed for use within NHS Wales for the treatment of the following infections in adults and children: acute otitis media in patients with tympanostomy tubes; acute otitis externa. Please refer to the AWMSG position statement on the appraisal of antimicrobial medicines. |
||
|
||
Medicine details |
||
| Medicine name | ciprofloxacin / dexamethasone (Cilodex®) | |
| Formulation | 3 mg/ml/1 mg/ml ear drops | |
| Reference number | 1966 | |
| Indication | Treatment of the following infections in adults and children: acute otitis media in patients with tympanostomy tubes; acute otitis externa |
|
| Company | Novartis Pharmaceuticals UK Ltd | |
| BNF chapter | Ear, nose & oropharynx | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 22/05/2013 | |
| Further information AWMSG position statement on the appraisal of antimicrobial medicines |
||